secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001493152-25-014872
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics appoints John R. Palumbo, healthcare veteran, to board effective Sept 22, 2025
--------------------------------------------------------------------------------

- John R. Palumbo appointed as Class B director, effective September 22, 2025, designated by convertible note holders.
- Palumbo brings 40 years of healthcare leadership, including roles at AmerisourceBergen, Allscripts, and ValueHealth.
- He will receive cash fees and equity awards per non-employee director compensation policy.
- He currently serves on boards of PM Pediatrics, ivWatch, Qless, and chairs Brado advisory board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315225014872/0001493152-25-014872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315225014872/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer